BioSpace News Archive

SpringWorks Therapeutics, Inc. announced that the company has entered into a clinical trial collaboration and supply agreement with Regeneron Pharmaceuticals, Inc. to evaluate nirogacestat, SpringWorks’ investigational gamma secretase inhibitor, in combination with Regeneron’s investigational bispecific antibody targeting B-cell maturation antigen and CD3, REGN5458, in patients with relapsed or refractory multiple myeloma.

ENHERTU ® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer.

Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in Japan Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination.

Amarin Corporation plc today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s first quarter 2022 financial results on Wednesday, May 4, 2022 at 8:00 a.m. ET.

Clover Biopharmaceuticals, Ltd. today announced additional positive data from two ongoing studies evaluating SCB-2019 (CpG 1018/Alum).

Immuron Limited is pleased to advise that a new request for funding has been considered to be eligible for award by the US Department of Defense funding body ‘Medical Technology Enterprise Consortium’ (MTEC).

Theralink Technologies today announced that it has significantly expanded the adoption of its Laser Capture Microdissection (LCM) and Reverse Phase Protein Array (RPPA) precision medicine technology to biopharmaceutical companies, including multinational healthcare corporations.

Albany NY, United States: According to the report by Transparency Market Research, the global interventional cardiology devices market has highly consolidated landscape.

Albany NY, United States: The global cardiac pacemaker market is likely to demonstrate healthy growth during the course of forecast period from 2015 till 2023.

Rise in the number of older population across the globe is projected to boost the demand for urgent care centers globally.